News
The party should use this as an opportunity to build toward universal coverage—working from these seven principles for ...
StoryPath debuts a mobile-first app offering bite-sized video CE courses for dental professionals, featuring award-winning ...
ProKidney Corp. (PROK) shares just saw a massive green day. Results from Phase 2 were compelling and the data sharply ...
PulseSight Therapeutics SAS, an ophthalmology biotech company developing disruptive non-viral vectorized therapies with minimally-invasive delivery technology, is pleased to announce that the first ...
Secured approval from the Regulation Agency for Medical and Pharmaceutical Activities (RAMPA) in Georgia for Phase 2B/3 ...
Investigator initiated exploratory clinical study being conducted in Israel pursuant to agreement with collaboration partner, PeriNessCompany evaluating systemic recombinant human DNase I (DNase I) in ...
New and Unprecedented Survival, Respiratory, and Biomarker Data Prove that NurOwn Helps People with ALS Live Longer and Live ...
3d
Stockhead on MSNASX biotechs join global race for cell therapy breakthroughsCell therapies represent a promising frontier in modern medicine, offering potential to treat, and in some cases cure ...
Two Delaware lawmakers who led the push to legalize marijuana are now seeking input from consumers and businesses as the ...
How to apply for the disability tax credit (DTC) by completing form T2201. A medical practitioner must certify the form before submitting the application.
These mobile units address critical access barriers by bringing FDA-approved targeted therapy directly to local clinics and communities through equipped RVs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results